Jupiter Neurosciences, Inc. (JUNS): Nilai pasar

Jupiter Neurosciences Inc (JUNS) currently relies on external capital, as drug development is in its early stages and cash flow remains negative. The business is based on the Jotrol platform, which creates a unique environment for delivering neuroprotectors to the brain. This chart illustrating a market valuation of 0.00 highlights the profit potential from selling resveratrol-based dementia therapies through government healthcare systems.

JUNS Jupiter Neurosciences Inc: Kapitalisasi pasar ing interval 04.12.2024 - 22.10.2026

JUNS (Jupiter Neurosciences, Inc.): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Jupiter Neurosciences Inc (JUNS):

Kutipan saham Jupiter Neurosciences|JUNS - Prakiraan konsensus analis|Nilai pasar Jupiter Neurosciences Inc

Analisis fundamental perusahaan:JUNS (Jupiter Neurosciences)

Sampel barang jupiterneurosciences.com

Jupiter Neurosciences Inc (JUNS) is developing the unique JOTROL platform featuring high resveratrol bioavailability. The total value of all outstanding shares determines the company's market capitalization. This metric measures market confidence in the assets, smoothing out random price spikes. Inelastic demand for the drug should ensure long-term growth of this indicator. However, impulsive buying at the peaks of the chart risks freezing investor capital.

Pesaing wigati

Biogen - Biji pasar|Kapitalisasi pasar Neurocrine NBIX|RGC - Nilai pasar|AXSM (Axsome Corp) - Kapitalisasi pasar|ACADIA Pharmaceuticals (ACAD) - Nilai pasar|XENE - Kapitalisasi pasar|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|Nilai pasar CeriBell, Inc.|PRTA (Prothena Corp) - Nilai pasar|Biji pasar ALEC (Alector, Inc.)|Kapitalisasi pasar Annexon Biosciences (ANNX)|Nilai pasar Omeros OMER|NGNE (Neurogene Therapeutics) - Biji pasar|AC Immune - Kapitalisasi pasar|Kapitalisasi pasar voyagertherapeutics.com VYGR|NMRA (Neumora Therapeutics, Inc.) - Biji pasar|SCLX: Nilai pasar|TVGN (Tevogen Bio Holdings, Inc.) - Kapitalisasi pasar|Nilai pasar Alpha Cognition Corp ACOG|Nilai pasar Cognition Therapeutics, Inc. (CGTX)|IKT (inhibikase.com) - Nilai pasar|Cassava Sciences - Biji pasar|Nilai pasar ASRT|COYA - Nilai pasar|VTGN (Vistagen Therapeutics) - Kapitalisasi pasar|OVID: Kapitalisasi pasar|Nilai pasar acumenpharm.com (ABOS)|Biji pasar CRVO|Kapitalisasi pasar Alterity Therapeutics Ltd|Nilai pasar Clene Inc. (CLNN)|PEPG (pepgen.com) - Nilai pasar|Nilai pasar Relmada Therapeutics RLMD|annovisbio.com (ANVS) - Nilai pasar|GRCE - Nilai pasar|Kapitalisasi pasar Firefly Neuroscience, Inc. AIFF|KLTO: Kapitalisasi pasar|Biji pasar NeuroSense Therapeutics Ltd.|RVPH (Reviva Pharmaceuticals) - Kapitalisasi pasar|MetaVia, Inc. (MTVA) - Kapitalisasi pasar|Kapitalisasi pasar NRXS|HSDT - Nilai pasar|Nilai pasar Passage Bio PASG|NEUP: Kapitalisasi pasar|Minerva Neurosciences - Kapitalisasi pasar|athira.com (ATHA) - Biji pasar|ADXN: Kapitalisasi pasar|Nilai pasar Alzamend Neuro (ALZN)|Nilai pasar Cyclerion Therapeutics Inc.|Protagenic (PTIX) - Kapitalisasi pasar|Biji pasar KTTA (Pasithea Therapeutics)|CRGT (cortigent.com) - Nilai pasar|Kapitalisasi pasar ATXI (Avenue Therapeutics, Inc.)|Kapitalisasi pasar Brainstorm Cell Therapeutics Inc. (BCLI)|CARA - Nilai pasar|CHRO (Chromocell) - Kapitalisasi pasar|ELYM: Kapitalisasi pasar|Biji pasar Intra-Cellular Therapies, Inc.|Nilai pasar Longboard Pharmaceuticals, Inc.|MRNS (Marinus Pharmaceuticals Inc) - Nilai pasar|Biji pasar NKGN (NKGen)|Kapitalisasi pasar NeuroBo Pharma (NRBO)|Nilai pasar Sage Therapeutics, Inc. SAGE|SNPX: Kapitalisasi pasar|TRVN - Nilai pasar|Kapitalisasi pasar Vigil Neuroscience VIGL|Anew Medical, Inc. (WENA) - Nilai pasar|Kapitalisasi pasar CERE